Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...

To date, six patients have been successfully enrolled into the trial, Of these, two patients were enrolled at Johns Hopkins University School of Medicine and four at Yale School of Medicine’s ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...

The interdisciplinary research team at the School of Medicine will work together to explore the effects of factors like ...

Dartmouth applied to hire a “program manager” for DEI through the system, according to an X thread by Sen. Schmitt. Likewise, ...

Stacker combed through Niche's 2023 Hardest Colleges to Get Into in America ranking to see which school is the most difficult ...

Membership recognizes individuals who have demonstrated outstanding professional achievements and commitment to service ...

The researchers suspected the pathway—known as the social perception pathway—might be functional very early in development.

Dr. Ruth Anderson Lawrence of the University of Rochester Medical Center had many titles, such as physician, toxicologist, ...

Talha Burki speaks with Fred Ramsdell, Mary Brunkow, and Shimon Sakaguchi about their Nobel-winning discoveries in peripheral immune tolerance.

An initiative involving a public university medical school and a for-profit corporation with payer and provider business ...